The PCSK9 inhibitors market is witnessing robust advancement fueled by rising cardiovascular disease prevalence and growing awareness of advanced lipid-lowering therapies. This industry is poised for significant transformation driven by innovation in biologics and evolving treatment paradigms targeting hypercholesterolemia and associated disorders.Market Size and Overview The PCSK9 inhibitors...